BRIEF-Zealand Pharma says diabetes drug Lyxumia approved in Europe

Mon Feb 4, 2013 2:08am EST

Related Topics

Feb 4 (Reuters) - Zealand Pharma A/S : * Announces once-daily lyxumia (lixisenatide) approved in Europe for the

treatment of type 2 diabetes * Under the agreement with Sanofi, the company is entitled to tiered low double-digit percentage royalties on global sales of Lyxumia

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.